Integrated Sensing Systems, Inc. awarded a patent for minimally-invasive procedures to anchor its miniature, wireless, batteryless, sensing implants
Michigan, USA, October 9, 2014: Integrated Sensing Systems, Inc. (ISSYS) announced that the U.S Patent Office has granted a utility patent entitled “Minimally Invasive Procedure for Monitoring a Physiological Parameter within an Internal Organ” (US Patent No. 8,322,346).
ISSYS designs and produces miniature, wireless, batteryless, intelligent, implantable sensors. The miniature sensing implants can be delivered and anchored in three approaches. The first approach utilizes an outpatient, percutaneous, trans-catheter delivery. In the second approach, the miniature implant is placed as an adjunct device during an already-establish surgery, such as heart valve repair. The third approach, which is covered by this patent, involves the anchoring of the miniature sensing implant through a minimally-invasive procedure. The patent has 22 claims and covers a wide range of medical applications.
ISSYS’ focus is on wireless implantable hemodynamic monitors (IHM) that are anchored within the left-side of the heart for non-invasive monitoring of hemodynamic parameters to assist long-term patient management of chronic heart diseases. Dr. Nader Najafi, ISSYS President and CEO, stated that, “ISSYS miniature sensing implants offer many practical features such as home monitoring capability and on demand wireless data capture. The medical staff is able to access and read the patient’s data anywhere in the world with an internet connection. The data is submitted and uploaded with the home monitoring device. ISSYS wireless implant system also allows long-term monitoring (i.e., Trending) of important parameters such as heart’s Filling Pressure.” ISSYS successfully completed the first year of a clinical study to monitor the left-side of the heart of patients with chronic heart failure (CHF) with promising results.